rexresearch.com
rexresearch1.com
Prion Deactivation Patents
Cannabidiol ... Ozone ... Melatonin ... Resveratrol ... Nattokinase ... Tobacco ...Bitter Orange ... Sulfpraphane ... Caffeine ... Safflower ... Cobalt ... PyridylPyrimidine ... Earthworm ... &c... :
https://worldwide.espacenet.com/patent/search/family/046130581/publication/KR101180744B1?q=ta%20all%20%22prion%22&queryLang=en
WO2009013506 -- CANNABIDIOL FOR USE IN THE TREATMENT OF TRANSMISSIBLE NEURODEGENERATIVE CONDITIONS
WO2011162805 -- PRION INACTIVATION USING OZONE
WO03066112 -- OZONE STERILIZATION PROCESS AND APPARATUS FOR DENATURING PRIONS
KR20130084047A -- NOVEL USE OF MELATONIN
KR20110097100A -- THE RESVERATROL FOR PREVENTION AND TREATMENT OF PRION DISEASE
JP2010120942A -- NATTOKINASE DECOMPOSING AND REDUCING AMYLOID FIBRIL ASSOCIATED WITH ALZHEIMER'S DISEASE, PRION DISEASE, AND OTHER AMYLOIDOSIS
CN103041032A -- Application of tobacco in preparation of anti-prion medicament
CN102940712A -- Application of immature bitter orange in preparation of anti-prion medicament
KR20150110056A -- COMPOSITION FOR PREVENTING OR TREATING PRION DISEASE COMPRISING SULFORAPHANE
KR20150065364A -- COMPOSITION FOR PREVENTING OR TREATING PRION DISEASE COMPRISING CAFFEINE
CN102727552A -- Application of safflower in preparing anti-prion medicines
DE10159972A1 -- Preventing and treating prion diseases and toxoplasmosis in ruminants, involves administration of cobalt compounds, directly or through feed
CA2521438 -- PRION PROTEIN BINDING MATERIALS AND METHODS OF USE
US2002172977 -- Covalent modification of abnormal prion protein
US2006078892 -- Prion protein binding materials and methods of use
NZ513215 -- Method and kit for extracting prion protein
US2005053583A1 -- Method of inhibiting prion protein
TW201808312A -- Abnormal prion protein infectiousness reduction method and pharmaceutical composition for preventive therapy of prion disease
US2010221745A1 -- ABNORMAL PRION PROTEIN BINDER, AND METHOD FOR DETECTION OF ABNORMAL PRION PROTEIN
US2006280745A1 -- Prion inhibition
KR20070098752A -- A METHOD AND SYSTEM FOR PRION INACTIVATION
US2008027025A1 -- Protection From And Treatment Of Prion Protein Infection
JP2006098342A -- ELECTROCHEMICAL DETECTING METHOD OF ABNORMAL PRION
US2011044975A1 -- TREATMENT OF PRION PROTEIN RELATED DISEASES
EP1736162A1 -- REMEDY FOR PRION DISEASE AND METHOD OF PRODUCING THE SAME
US2017326108A1 -- COMPOSITIONS AND METHODS FOR REDUCING PRION LEVELS
CA2502954A1 -- PRION DECONTAMINATION
JP2006180826A -- METHOD FOR WASHING NATURAL CASING WITH PRION-SPLITTING ENZYME
CN101316933A -- Method for concentrating, purifying and removing prion protein
JP2004292437A -- METHOD FOR INHIBITING PROPAGATION OF ABNORMAL PRION PROTEIN
WO2005077382A1 -- PRION GROWTH INHIBITOR
CN101049510A -- A method and system for prion inactivation
CN102277356A -- Knockout method of prion gene of goats
WO02093164A2 -- PYRIDYLPYRIMIDINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST PRION DISEASES
JP2007252288A -- COMPOSITION FOR TREATING HUMAN PRION DISEASE
BG105791A -- METHOD AND KIT FOR EXTRACTING PRION PROTEIN
WO2014184317A1 -- METHOD FOR INACTIVATING A PRION PROTEIN
US2010074962A1 -- DEGRADATION OF PRION PROTEIN AND REDUCED PRION INFECTIVITY BY EARTHWORM HOMOGENATES
US6221614B1 -- Removal of prions from blood, plasma and other liquids
JP2001000512A -- PRION INACTIVATING AGENT
WO2011162480A2 -- COMPOSITION FOR TREATING PRION DISEASES COMPRISING HIF-1? AGONIST
CA2620047A1 -- PRION INACTIVATION
JP2008281557A -- PRION DISEASE CURATIVE MEDICINE AND ITS SCREENING METHOD
JP2010209040A -- AGENT FOR PREVENTION AND/OR TREATMENT OF PRION DISEASE AND METHOD FOR SUPPRESSING EXPRESSION OF ABNORMAL PRION PROTEIN
UA32547U -- USE OF PENTOSAN POLYSULPHATE (SP-54) AS INHIBITOR OF PHYSIOLOGICAL PRION-PROTEIN EXPRESSION IN VITRO
CN1494438A -- Prion disinfection
US2009258419A1 -- METHOD FOR REMOVING PRION PROTEIN
JP2014140370A -- METHOD FOR DETECTING PRION INFECTION
US2008248556A1 -- USE OF SONICATION TO ELIMINATE PRIONS
EP2311323A1 -- Methods for degradation of protein deposits and prions
KR101746401B1 -- Composition for the prevention or treatment of bovine spongiform encephalopathy containing E-34-dihydroxystyryl 234-trihydroxybutanoate
US2005255525A1 -- Safe method for isolation of prion protein and diagnosis of transmissible spongiform encephalopathies
JP2003321690A -- METHOD FOR TREATING MEAT AND BONE MEAL OR MEAT TREATMENT WASTE
JP2005120002A -- INHIBITOR AGAINST SPECIFIC STRUCTURE FORMATION OF AMYLOID PRECURSOR
WO2008041134 -- USE OF CHLORINE GUANABENZ DERIVATIVES FOR TREATING PRION-BASED DISEASES
WO2005092114 -- COMPOSITIONS AND METHODS FOR DESTRUCTION OF PRION INFECTIOUS PROTEINS
GB2394663A -- Prion decontamination
JP2005287322A -- METHOD FOR DECOMPOSITION OF PRION WITH WOOD DECAYING BASIDIOMYCETE
KR20150065361A -- COMPOSITION FOR PREVENTING OR TREATING PRION DISEASE COMPRISING CAFFEINE
KR101605522B1 -- Compositions for prevention or treatment of Prion disease containing 2-3-hydroxy-4-4-3-methoxyphenoxy-1H-pyrazol-3-ylphenoxyaceto-hydrazide or pharmaceutically acceptable salts thereof as an active ingredient
JP2018035099A -- PRION DISEASE PREVENTIVE/THERAPEUTIC AGENT
US2016368885A1 -- MALEATE OF ANTI-PRION COMPOUND, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION THEREOF
WO03080665A2 -- TREATMENT OF TSE INFECTION
JP2003040778A -- COMPOSITION FOR INHIBITING PRODUCTION OF PATHOLOGICAL PRION PROTEIN AND METHOD FOR INHIBITING PRODUCTION OF PATHOLOGICAL PRION PROTEIN
WO2006002540A1 -- OLIGONUCLEOTIDES TARGETING PRION DISEASES AND USES
US2011311510A1 -- Compositions and methods for prion decontamination
KR101180744B1 -- Composition for preventing or treating prion disease comprising cholesterol
WO0100235A1 -- PRION PROTEIN BINDING PROTEINS AND USES THEREOF
US6426409B1 -- Nucleic acid molecules that bind prion proteins and processes for the production thereof
WO2017109170A1 -- COMPOSITION AND USES THEREOF
KR101351597B1 -- Method for inhibiting apoptosis caused by PrPsc using lactoferrin from colostrum
AU2005100872A4 -- Prion disinfection
WO2008053764A1 -- ANTI-PRION ACTIVE COMPOUND, ANTI-PRION ACTIVE AGENT, AND METHOD FOR INHIBITION OF THE PRODUCTION OF ABNORMAL PRION PROTEIN
WO2004003505A2 -- METHODS FOR DETECTING AND INACTIVATING A PRION
WO2005025487A2 -- OLIGONUCLEOTIDES TARGETING PRION DISEASES
US2010092447A1 -- METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES
CA2488502A1 -- REMOVAL OF PRION INFECTIVITY
JP2009203481A -- DECONTAMINATION OF SURFACE CONTAMINATED WITH PRION-INFECTED SUBSTANCE USING OXIDIZING AGENT-BASED FORMULATION
US2014329863A1 -- NOVEL ANTIPRION COMPOUNDS
WO2007137808A1 -- COMPOSITIONS COMPRISING OLIGOSACCHARIDES FOR TREATING PRION DISEASE
JP2008290959A -- ABNORMAL PRION-DECOMPOSING ENZYME INHIBITORY SUBSTANCE AND USE OF THE SAME
AU2013262415A1 -- Oligonucleotide chelate complex methods
US2014377744A1 -- NUCLEIC ACID LIGANDS AGAINST INFECTIOUS PRIONS
CA2911040A1 -- TREATING NEURAL DISEASE WITH TYROSINE KINASE INHIBITORS
CA2446127A1 -- DESTRUCTION OF PRIONS USING VIBRIOLYSIN OR VARIANTS THEREOF
WO03041733A1 -- PRION-DETECTION BUSINESS METHODS
WO03006426A1 -- AROMATIC GUANYLHYDRAZONES AS EFFECTIVE COMPOUNDS AGAINST NEURODISEASES
JP2004083522A -- DEACTIVATION METHOD OF NOXIOUS PROTEIN AND DEACTIVATION METHOD OF INFECTIVE PRION PROTEIN
JP2005192415A -- PEPTIDE FOR TREATING PRION DISEASE AND UTILIZATION THEREOF
CN102366634A -- Sterilization method for prion
US2002150631A1 -- Methods of treating prion disease in mammals
US6365359B1 -- Inhibitors of prion formation
JP4132151B2 -- INACTIVATION OF PRION
WO02092110A1 -- NEW USE OF NATURAL PLANT POLYPHENOL AND MEDICAMENT AND/OR HEALTH CARE PRODUCT CONTAINING NATURAL PLANT POLYPHENOL
JP2016202477A -- METHOD FOR INACTIVATING PRIONS
JP2007175107A -- METHOD FOR INACTIVATING PRION
KR100881636B1 -- Treatment for prion disease
US2003049249A1 -- Agent
WO2019199776A1 -- COMBINATION THERAPIES FOR THE TREATMENT OF AMYOTROPIC LATERAL SCLEROSIS AND RELATED DISORDERS
JP2006043690A -- METHOD FOR TREATING SPECIFIED DANGEROUS REGION CONTAINING ABNORMAL PRION PROTEIN BEING CAUSE OF ONSET OF BSE WITH SUBCRITICAL WATER